Skip to content

Titan Pharmaceuticals, Inc.: filings

Every Titan Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 58 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2025-08-14fiscal Q2 202528800001829126-25-006318
10-Q2025-05-14fiscal Q1 202528560001829126-25-003656
10-K2025-03-20fiscal FY 202437680001829126-25-001934
10-Q2025-01-03fiscal Q3 202434950001829126-25-000026
10-Q2024-08-15fiscal Q2 202431850001829126-24-005552
10-Q2024-05-15fiscal Q1 202432650001829126-24-003401
10-K2024-04-01fiscal FY 2023431190001829126-24-002110
10-Q2023-11-14fiscal Q3 2023371000001829126-23-007422
10-Q2023-08-14fiscal Q2 202335930001829126-23-005424
10-Q2023-05-15fiscal Q1 202332670001829126-23-003437
10-K2023-03-31fiscal FY 202237720001829126-23-002504
10-Q2022-11-14fiscal Q3 202235940001829126-22-019258
10-Q2022-08-11fiscal Q2 202233880001104659-22-089444
10-Q2022-05-16fiscal Q1 202231660001104659-22-061315
10-K2022-03-25fiscal FY 202138770001410578-22-000518
10-Q2021-11-15fiscal Q3 202133910001410578-21-000270
10-Q2021-08-16fiscal Q2 202131790001104659-21-106404
10-Q2021-05-17fiscal Q1 202132670001104659-21-068039
10-K2021-03-31fiscal FY 202035710001104659-21-044732
10-Q2020-11-16fiscal Q3 202032870001104659-20-125466
10-Q2020-08-14fiscal Q2 202033850001104659-20-095091
10-Q2020-05-15fiscal Q1 202033690001104659-20-062136
10-K2020-03-30fiscal FY 2019421160001104659-20-040354
10-Q2019-11-14fiscal Q3 2019381100001104659-19-064166
10-Q2019-08-14fiscal Q2 201934880001144204-19-040066
10-Q2019-05-15fiscal Q1 201934720001144204-19-026546
10-K/A2019-04-02fiscal FY 2018431480001144204-19-017559
10-K2019-04-01fiscal FY 2018431480001144204-19-017459
10-Q2018-11-14fiscal Q3 2018381080001144204-18-059914
10-Q2018-08-14fiscal Q2 2018381080001144204-18-044671
10-Q2018-05-15fiscal Q1 201836750001144204-18-028837
10-K2018-04-02fiscal FY 2017401390001144204-18-018448
10-Q2017-11-09fiscal Q3 201734980001144204-17-057514
10-Q2017-08-09fiscal Q2 201731920001144204-17-041432
10-Q2017-05-10fiscal Q1 201731640001144204-17-025807
10-K2017-03-16fiscal FY 2016361270001144204-17-014986
10-Q2016-11-09fiscal Q3 201630880001144204-16-132571
10-Q2016-08-09fiscal Q2 201631920001144204-16-117543
10-Q2016-05-10fiscal Q1 201631640001144204-16-100320
10-K2016-03-15fiscal FY 2015361270001144204-16-088046
10-Q2015-11-16fiscal Q3 201531900001144204-15-065794
10-Q2015-08-13fiscal Q2 201531900001144204-15-049078
10-Q2015-05-13fiscal Q1 201531640001144204-15-030079
10-K2015-03-31fiscal FY 2014361270001144204-15-019881
10-Q2014-11-13fiscal Q3 201431880001144204-14-067785
10-Q2014-08-13fiscal Q2 201431880001144204-14-049264
10-Q2014-05-14fiscal Q1 201430620001144204-14-030446
10-K2014-03-31fiscal FY 2013351230001144204-14-019329
10-Q2013-11-14fiscal Q3 201334980001144204-13-061720
10-Q2013-08-14fiscal Q2 201333940001193125-13-334782
10-Q2013-05-15fiscal Q1 201333680001193125-13-222505
10-K2013-03-18fiscal FY 2012351040001193125-13-111045
10-Q2012-11-09fiscal Q3 201228720001193125-12-463364
10-Q2012-08-09fiscal Q2 201228720001193125-12-347860
10-Q2012-05-10fiscal Q1 201228560001193125-12-225187
10-K2012-03-15fiscal FY 201130770001193125-12-117326
10-Q2011-11-14fiscal Q3 201127700001193125-11-310949
10-Q/A2011-08-17fiscal Q2 201127690001193125-11-224561

Inspect the source

Entity
Titan Pharmaceuticals, Inc. / CIK 0000910267
Captured
2026-09-21T17:17:21.539Z
SEC response SHA-256
452f10f2ccebf3c2fc56928a34e465f1e463941958497d363e8fdef6c3b42dd1

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000910267.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))